From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.” “This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate […]
On January 20, 2019, AZBio hosted a thought leadership event at Barrett-Jackson Scottsdale featuring a panel discussion on Health Innovation with Dr. Anna Barker and Dr. George Poste. During the discussion, Dr. Poste, shared his thoughts on the need for governments and our industry to prepare for global pandemics and what the Bipartisan Commission on […]
Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens
The authorization is limited to testing performed at the Rutgers Clinical Genomics Laboratory using their molecular LDT COVID-19 authorized test for saliva specimens collected using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device. FDA states “It is important to note that this is not a general authorization for at-home collection of patient samples using other […]
Sofia® 2 SARS Antigen FIA Point-of-Care test offers positive results in 15 minutes
- Digital RESI – Three Day Conference
- 06/08/2020 - 06/10/2020
- NCCN Oncology Policy Summit: Accelerating Advances in Cancer Care Research: A Look Back at the 21st Century Cures Act in 2020
- AZBioPEERS: Building a Company that is Investment Ready
- Real World Evidence - Meet the future with confidence.
- AZBioPEERS: What is my company worth? Establishing a valuation